Therapeutic angiogenesis using genetically engineered human endothelial cells
Cell therapy holds promise as a method for the treatment of ischemic disease. However, one significant challenge to the efficacy of cell therapy is poor cell survival in vivo. Here we describe a non-viral, gene therapy approach to improve the survival and engraftment of cells transplanted into ische...
Main Authors: | Cho, Seung-Woo, Son, Sun Mi, Park, Hyun-Ji, Green, Jordan J., Bogatyrev, Said, Mei, Ying, Park, Sohyun, Anderson, Daniel Griffith, Langer, Robert S, Yang, Fan |
---|---|
Other Authors: | Harvard University--MIT Division of Health Sciences and Technology |
Format: | Article |
Language: | en_US |
Published: |
Elsevier
2016
|
Online Access: | http://hdl.handle.net/1721.1/101124 https://orcid.org/0000-0001-5629-4798 https://orcid.org/0000-0003-4255-0492 |
Similar Items
-
Genetic Engineering of Human Stem Cells for Enhanced Angiogenesis Using Biodegradable Polymeric Nanoparticles
by: Cho, Seung Woo, et al.
Published: (2011) -
Endothelial TRPV1 as an Emerging Molecular Target to Promote Therapeutic Angiogenesis
by: Sharon Negri, et al.
Published: (2020-05-01) -
Endothelial Cell Glucose Metabolism and Angiogenesis
by: Wa Du, et al.
Published: (2021-02-01) -
Hybrid spheroids containing mesenchymal stem cells promote therapeutic angiogenesis by increasing engraftment of co-transplanted endothelial colony-forming cells in vivo
by: Young Cheol Song, et al.
Published: (2023-08-01) -
Hexane Fraction of <i>Adenophora triphylla</i> var. <i>japonica</i> Root Extract Inhibits Angiogenesis and Endothelial Cell-Induced Erlotinib Resistance in Lung Cancer Cells
by: Hyun-Ji Park, et al.
Published: (2024-01-01)